上海研生实业有限公司品牌商

9

手机商铺

qrcode
商家活跃:
产品热度:
  • NaN
  • 0
  • 0
  • 2
  • 2
品牌商

上海研生实业有限公司

入驻年限:9

  • 联系人:

    王经理

  • 所在地区:

    上海

  • 业务范围:

    试剂、技术服务、细胞库 / 细胞培养

  • 经营模式:

    生产厂商 经销商 代理商

在线沟通
推荐产品

HLCL9B10厂家

品牌:上海研生

询价

询价

HLCL9C3厂家

品牌:上海研生

询价

询价

吐温80(细胞培养级)9005-65-6

品牌:上海研生

询价

询价
查看全部产品

技术资料/正文

Targeted Therapy for Gut Microbiota: Candidates for a Novel Strategy to Ameliorate Type 2 Diabetes MellitusIF:1.40

19 人阅读发布时间:2026-01-16 10:54

技术资料图片1

技术资料图片2

技术资料图片3

技术资料图片4

Amino acids are fermented by intestinal bacteria in the dis tal colon, with protein fermentation yielding higher amounts of BCAAs and potentially toxic substrates, such as ammo nia, than carbohydrate fermentation (Rinninella et  al.  2019).
BCAAs, including leucine, isoleucine, and valine, play critical roles in maintaining the intestinal immune system and activat
ing the intestinal mucosal immune barrier (Zhang et al. 2021).Disruption of BCAA metabolism can lead to the accumulation
of toxic metabolic intermediates and increased activation of mammalian target of rapamycin complex 1 (mTORC1), a key
regulator of cell growth. This dysregulation can impair insu lin signalling (Zhou et  al.  2019) and promote mitochondrial
dysfunction and apoptosis in pancreatic β-cells (Hamamah et al. 2024; Lynch and Adams 2014). Enhancing BCAA catabo
lism in the gut may modulate the intestinal BCAA-mammalian target of rapamycin complex 1 insulin receptor substrate
1-phosphatidylinositol 3 kinase-AKT axis, thereby mitigating  the harmful effects of BCAAs on the insulin receptor substrate
1 signalling pathway and improving T2DM (Wang et al. 2024)(Figure  5). Furthermore, disturbances in the gut microbiota
have been shown to exacerbate IR and disrupt glucose metab olism by increasing the circulating levels of BCAAs (Pedersenet al. 2016). For instance, Prevotella induces the expression of genes associated with BCAA biosynthesis, while reducing the expression of genes involved in BCAA degradation, contributing to IR in patients (Pedersen et al. 2016). Additionally, the quantity of BCAAs absorbed in the intestine correlates with the abun dance of C. difficile (Saad et al. 2016). Modifying the composi tion of the gut microbiota in diabetic mice to reduce BCAA levels can alleviate the symptoms associated with T2DM (Wu, Zuo,et al. 2021). Analysis of faecal specimens from 15 patients with diabetes and 22 healthy controls revealed that the abundance 

感谢中国广东省微生物靶向治疗工程技术研究中心胃肠病学部,广东省药科大学第一附属医院,广州,中国 |2广东省药品制剂研究与评价重点实验室分享文献!

 

资料格式:

Microbial Biotechnology - 2025 - Wang - Targeted Therapy for Gut Microbiota Candidates for a Novel Strategy to Ameliorate.pdf

查看详细文档

上一篇

人cAMP反应元件结合蛋白ELISA检测试剂盒.docx

下一篇

Metabolic Reprogramming: A Crucial Contributor to Anticancer Drug Resistance IF:9.90

我的询价